<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27-pharmaceutics-12-00688">
 <label>27.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ceresa</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hutton</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lajarin-Cuesta</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Heaton</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Hargreaves</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Fracchia</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>De Rienzo</surname>
    <given-names>M.A.D.</given-names>
   </name>
  </person-group>
  <article-title>Production of Mannosylerythritol Lipids (MELs) to be Used as Antimicrobial Agents Against S. aureus ATCC 6538</article-title>
  <source>Curr. Microbiol.</source>
  <year>2020</year>
  <volume>77</volume>
  <fpage>1373</fpage>
  <lpage>1380</lpage>
  <pub-id pub-id-type="doi">10.1007/s00284-020-01927-2</pub-id>
  <pub-id pub-id-type="pmid">32123984</pub-id>
 </element-citation>
</ref>
